{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:46:27Z","timestamp":1791855987819,"version":"4.3.4"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"national institutes of health","doi-asserted-by":"publisher","award":["T32GM008750"],"award-info":[{"award-number":["T32GM008750"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"national institutes of health","doi-asserted-by":"publisher","award":["T32AA013527"],"award-info":[{"award-number":["T32AA013527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"national institutes of health","doi-asserted-by":"publisher","award":["R21AA025806"],"award-info":[{"award-number":["R21AA025806"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014894","name":"emerald foundation","doi-asserted-by":"crossref","award":["518432"],"award-info":[{"award-number":["518432"]}],"id":[{"id":"10.13039\/100014894","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Inflammatory bowel disease (IBD) is established to drive pathological sequelae in organ systems outside the intestine, including the central nervous system (CNS). Many patients exhibit cognitive deficits, particularly during disease flare. The connection between colonic inflammation and neuroinflammation remains unclear and characterization of the neuroinflammatory phenotype in the brain during colitis is ill-defined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Transgenic mice expressing a bioluminescent reporter of active caspase-1 were treated with 2% dextran sodium sulfate (DSS) for 7\u00a0days to induce acute colitis, and colonic, systemic and neuroinflammation were assessed. In some experiments, mice were prophylactically treated with paquinimod (ABR-215757) to inhibit S100A9 inflammatory signaling. As a positive control for peripheral-induced neuroinflammation, mice were injected with lipopolysaccharide (LPS). Colonic, systemic and brain inflammatory cytokines and chemokines were measured by cytokine bead array (CBA) and Proteome profiler mouse cytokine array. Bioluminescence was quantified in the brain and caspase activation was confirmed by immunoblot. Immune cell infiltration into the CNS was measured by flow cytometry, while light sheet microscopy was used to monitor changes in resident microglia localization in intact brains during DSS or LPS-induced neuroinflammation. RNA sequencing was performed to identify transcriptomic changes occurring in the CNS of DSS-treated mice. Expression of inflammatory biomarkers were quantified in the brain and serum by qRT-PCR, ELISA and WB.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>DSS-treated mice exhibited clinical hallmarks of colitis, including weight loss, colonic shortening and inflammation in the colon. We also detected a significant increase in inflammatory cytokines in the serum and brain, as well as caspase and microglia activation in the brain of mice with ongoing colitis. RNA sequencing of brains isolated from DSS-treated mice revealed differential expression of genes involved in the regulation of inflammatory responses. This inflammatory phenotype was similar to the signature detected in LPS-treated mice, albeit less robust and transient, as inflammatory gene expression returned to baseline following cessation of DSS. Pharmacological inhibition of S100A9, one of the transcripts identified by RNA sequencing, attenuated colitis severity and systemic and neuroinflammation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggest that local inflammation in the colon drives systemic inflammation and neuroinflammation, and this can be ameliorated by inhibition of the S100 alarmin, S100A9.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12974-021-02317-6","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T08:04:09Z","timestamp":1636531449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["DSS-induced inflammation in the colon drives a proinflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod"],"prefix":"10.1186","volume":"18","author":[{"given":"Sarah","family":"Talley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasa","family":"Valiauga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail R.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashkoor A.","family":"Choudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"issue":"4","key":"2317_CR1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","volume":"12","author":"AN Ananthakrishnan","year":"2015","unstructured":"Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12(4):205\u201317.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"2317_CR2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","volume":"142","author":"NA Molodecky","year":"2012","unstructured":"Molodecky NA, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54 e42; quiz e30.","journal-title":"Gastroenterology"},{"issue":"1","key":"2317_CR3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/CMR.15.1.79-94.2002","volume":"15","author":"BA Hendrickson","year":"2002","unstructured":"Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15(1):79\u201394.","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"2317_CR4","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","volume":"21","author":"SR Vavricka","year":"2015","unstructured":"Vavricka SR, et al. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1982\u201392.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"2317_CR5","first-page":"235","volume":"7","author":"JS Levine","year":"2011","unstructured":"Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2011;7(4):235\u201341.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"3","key":"2317_CR6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/MIB.0000000000000620","volume":"22","author":"A Mikocka-Walus","year":"2016","unstructured":"Mikocka-Walus A, et al. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22(3):752\u201362.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"2317_CR7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/1751-2980.12644","volume":"19","author":"T Geiss","year":"2018","unstructured":"Geiss T, et al. Risk of depression in patients with inflammatory bowel disease. J Dig Dis. 2018;19(8):456\u201367.","journal-title":"J Dig Dis"},{"key":"2317_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fnhum.2019.00107","volume":"13","author":"W Fan","year":"2019","unstructured":"Fan W, et al. Aberrant brain function in active-stage ulcerative colitis patients: a resting-state functional MRI study. Front Hum Neurosci. 2019;13:107.","journal-title":"Front Hum Neurosci"},{"key":"2317_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006854","author":"CE Whitehouse","year":"2019","unstructured":"Whitehouse CE, et al. Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders. Neurology. 2019. https:\/\/doi.org\/10.1212\/WNL.0000000000006854.","journal-title":"Neurology"},{"issue":"4","key":"2317_CR10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/2050640616663397","volume":"5","author":"DR van Langenberg","year":"2017","unstructured":"van Langenberg DR, et al. Cognitive impairment in Crohn\u2019s disease is associated with systemic inflammation, symptom burden and sleep disturbance. United European Gastroenterol J. 2017;5(4):579\u201387.","journal-title":"United European Gastroenterol J"},{"key":"2317_CR11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jpsychores.2016.06.001","volume":"87","author":"R Neuendorf","year":"2016","unstructured":"Neuendorf R, et al. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70\u201380.","journal-title":"J Psychosom Res"},{"issue":"1","key":"2317_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/gutjnl-2020-320789","volume":"70","author":"B Zhang","year":"2021","unstructured":"Zhang B, et al. Inflammatory bowel disease is associated with higher dementia risk: a nationwide longitudinal study. Gut. 2021;70(1):85\u201391.","journal-title":"Gut"},{"issue":"s2","key":"2317_CR13","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.3233\/JPD-191729","volume":"9","author":"T Brudek","year":"2019","unstructured":"Brudek T. Inflammatory bowel diseases and Parkinson\u2019s disease. J Parkinsons Dis. 2019;9(s2):S331\u201344.","journal-title":"J Parkinsons Dis"},{"key":"2317_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081191","author":"S Park","year":"2019","unstructured":"Park S, et al. Patients with inflammatory bowel disease are at an increased risk of parkinson\u2019s disease: a South Korean nationwide population-based study. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8081191.","journal-title":"J Clin Med"},{"issue":"1","key":"2317_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gutjnl-2017-315666","volume":"68","author":"M Villumsen","year":"2019","unstructured":"Villumsen M, et al. Inflammatory bowel disease increases the risk of Parkinson\u2019s disease: a Danish nationwide cohort study 1977\u20132014. Gut. 2019;68(1):18\u201324.","journal-title":"Gut"},{"issue":"5","key":"2317_CR16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/MIB.0000000000000735","volume":"22","author":"JC Lin","year":"2016","unstructured":"Lin JC, et al. Association between Parkinson\u2019s disease and inflammatory bowel disease: a nationwide Taiwanese retrospective cohort study. Inflamm Bowel Dis. 2016;22(5):1049\u201355.","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"2317_CR17","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1471-4159.2010.06879.x","volume":"114","author":"RF Villaran","year":"2010","unstructured":"Villaran RF, et al. Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease. J Neurochem. 2010;114(6):1687\u2013700.","journal-title":"J Neurochem"},{"issue":"9","key":"2317_CR18","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.4049\/jimmunol.1900619","volume":"203","author":"S Talley","year":"2019","unstructured":"Talley S, et al. A caspase-1 biosensor to monitor the progression of inflammation in vivo. J Immunol. 2019;203(9):2497\u2013507.","journal-title":"J Immunol"},{"issue":"1","key":"2317_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/jpet.117.245290","volume":"365","author":"N Tajuddin","year":"2018","unstructured":"Tajuddin N, Kim HY, Collins MA. PARP inhibition prevents ethanol-induced neuroinflammatory signaling and neurodegeneration in rat adult-age brain slice cultures. J Pharmacol Exp Ther. 2018;365(1):117\u201326.","journal-title":"J Pharmacol Exp Ther"},{"key":"2317_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100035","author":"EA Bordt","year":"2020","unstructured":"Bordt EA, et al. Isolation of microglia from mouse or human tissue. STAR Protoc. 2020. https:\/\/doi.org\/10.1016\/j.xpro.2020.100035.","journal-title":"STAR Protoc"},{"key":"2317_CR21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fncel.2014.00430","volume":"8","author":"F Calabrese","year":"2014","unstructured":"Calabrese F, et al. Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity. Front Cell Neurosci. 2014;8:430.","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"2317_CR22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/cei.12136","volume":"173","author":"AE Ostvik","year":"2013","unstructured":"Ostvik AE, et al. Expression of toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2. Clin Exp Immunol. 2013;173(3):502\u201311.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"2317_CR23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/gut.38.3.414","volume":"38","author":"BS Nielsen","year":"1996","unstructured":"Nielsen BS, et al. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut. 1996;38(3):414\u201320.","journal-title":"Gut"},{"key":"2317_CR24","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1038\/ncomms5593","volume":"5","author":"T Vogl","year":"2014","unstructured":"Vogl T, et al. Alarmin S100A8\/S100A9 as a biomarker for molecular imaging of local inflammatory activity. Nat Commun. 2014;5:4593.","journal-title":"Nat Commun"},{"key":"2317_CR25","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, et al. S100A8\/A9 in inflammation. Front Immunol. 2018;9:1298.","journal-title":"Front Immunol"},{"issue":"6","key":"2317_CR26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gut.2008.170019","volume":"58","author":"D Foell","year":"2009","unstructured":"Foell D, Wittkowski H, Roth J. Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. Gut. 2009;58(6):859\u201368.","journal-title":"Gut"},{"issue":"5","key":"2317_CR27","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000201267","volume":"56","author":"N Lugering","year":"1995","unstructured":"Lugering N, et al. Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8\/14 in Crohn\u2019s disease. Digestion. 1995;56(5):406\u201314.","journal-title":"Digestion"},{"issue":"11","key":"2317_CR28","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/00365520701416709","volume":"42","author":"ST Leach","year":"2007","unstructured":"Leach ST, et al. Serum and mucosal S100 proteins, calprotectin (S100A8\/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol. 2007;42(11):1321\u201331.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"2317_CR29","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1007\/s12264-018-0288-5","volume":"34","author":"Y Han","year":"2018","unstructured":"Han Y, et al. Cortical inflammation is increased in a DSS-induced colitis mouse model. Neurosci Bull. 2018;34(6):1058\u201366.","journal-title":"Neurosci Bull"},{"key":"2317_CR30","doi-asserted-by":"crossref","first-page":"9970","DOI":"10.1038\/srep09970","volume":"5","author":"F Reichmann","year":"2015","unstructured":"Reichmann F, et al. Dextran sulfate sodium-induced colitis alters stress-associated behaviour and neuropeptide gene expression in the amygdala-hippocampus network of mice. Sci Rep. 2015;5:9970.","journal-title":"Sci Rep"},{"issue":"1","key":"2317_CR31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12974-018-1296-0","volume":"15","author":"H Gong","year":"2018","unstructured":"Gong H, et al. Hippocampal Mrp8\/14 signaling plays a critical role in the manifestation of depressive-like behaviors in mice. J Neuroinflammation. 2018;15(1):252.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"2317_CR32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/infdis\/jiv028","volume":"212","author":"C Wache","year":"2015","unstructured":"Wache C, et al. Myeloid-related protein 14 promotes inflammation and injury in meningitis. J Infect Dis. 2015;212(2):247\u201357.","journal-title":"J Infect Dis"},{"key":"2317_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217838","author":"GA Czapski","year":"2020","unstructured":"Czapski GA, et al. Acute systemic inflammatory response alters transcription profile of genes related to immune response and Ca(2+) homeostasis in hippocampus; relevance to neurodegenerative disorders. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21217838.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2317_CR34","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.bbadis.2009.10.003","volume":"1792","author":"G Ziegler","year":"2009","unstructured":"Ziegler G, et al. Mrp-8 and -14 mediate CNS injury in focal cerebral ischemia. Biochim Biophys Acta. 2009;1792(12):1198\u2013204.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"2317_CR35","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.ajpath.2013.01.032","volume":"182","author":"S Helmersson","year":"2013","unstructured":"Helmersson S, et al. Amelioration of experimental autoimmune encephalomyelitis by the quinoline-3-carboxamide paquinimod: reduced priming of proinflammatory effector CD4(+) T cells. Am J Pathol. 2013;182(5):1671\u201380.","journal-title":"Am J Pathol"},{"issue":"12","key":"2317_CR36","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.intimp.2004.07.009","volume":"4","author":"H Carlsten","year":"2004","unstructured":"Carlsten H, et al. The impact of a new immunomodulator oxo-quinoline-3-carboxamide on the progression of experimental lupus. Int Immunopharmacol. 2004;4(12):1515\u201323.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"2317_CR37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196598","volume":"13","author":"S Tahvili","year":"2018","unstructured":"Tahvili S, et al. Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse. PLoS ONE. 2018;13(5): e0196598.","journal-title":"PLoS ONE"},{"issue":"12","key":"2317_CR38","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1136\/annrheumdis-2014-206517","volume":"74","author":"RF Schelbergen","year":"2015","unstructured":"Schelbergen RF, et al. Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis. Ann Rheum Dis. 2015;74(12):2254\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"2317_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203228","volume":"13","author":"N Fransen Pettersson","year":"2018","unstructured":"Fransen Pettersson N, et al. The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis. PLoS ONE. 2018;13(9): e0203228.","journal-title":"PLoS ONE"},{"issue":"6","key":"2317_CR40","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1172\/JCI92450","volume":"127","author":"MJ Kraakman","year":"2017","unstructured":"Kraakman MJ, et al. Neutrophil-derived S100 calcium-binding proteins A8\/A9 promote reticulated thrombocytosis and atherogenesis in diabetes. J Clin Invest. 2017;127(6):2133\u201347.","journal-title":"J Clin Invest"},{"issue":"1","key":"2317_CR41","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1038\/s41598-017-04990-1","volume":"7","author":"G Ellrichmann","year":"2017","unstructured":"Ellrichmann G, et al. Laquinimod treatment in the R6\/2 mouse model. Sci Rep. 2017;7(1):4947.","journal-title":"Sci Rep"},{"issue":"1","key":"2317_CR42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12974-018-1075-y","volume":"15","author":"A Katsumoto","year":"2018","unstructured":"Katsumoto A, et al. Laquinimod attenuates inflammation by modulating macrophage functions in traumatic brain injury mouse model. J Neuroinflammation. 2018;15(1):26.","journal-title":"J Neuroinflammation"},{"key":"2317_CR43","first-page":"8896108","volume":"2021","author":"JU Lee","year":"2021","unstructured":"Lee JU, et al. Inhibitory effect of paquinimod on a murine model of neutrophilic asthma induced by ovalbumin with complete Freund\u2019s adjuvant. Can Respir J. 2021;2021:8896108.","journal-title":"Can Respir J"},{"issue":"5","key":"2317_CR44","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/art.33493","volume":"64","author":"AA Bengtsson","year":"2012","unstructured":"Bengtsson AA, et al. Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus. Arthritis Rheum. 2012;64(5):1579\u201388.","journal-title":"Arthritis Rheum"},{"issue":"9630","key":"2317_CR45","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(08)60918-6","volume":"371","author":"G Comi","year":"2008","unstructured":"Comi G, et al. Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet. 2008;371(9630):2085\u201392.","journal-title":"Lancet"},{"issue":"6","key":"2317_CR46","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1212\/01.WNL.0000154520.48391.69","volume":"64","author":"C Polman","year":"2005","unstructured":"Polman C, et al. Treatment with laquinimod reduces development of active MRI lesions in relapsing MS. Neurology. 2005;64(6):987\u201391.","journal-title":"Neurology"},{"issue":"4","key":"2317_CR47","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1371\/journal.pbio.1000097","volume":"7","author":"P Bjork","year":"2009","unstructured":"Bjork P, et al. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol. 2009;7(4):e97.","journal-title":"PLoS Biol"},{"issue":"12","key":"2317_CR48","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.it.2014.10.004","volume":"35","author":"EM Creagh","year":"2014","unstructured":"Creagh EM. Caspase crosstalk: integration of apoptotic and innate immune signalling pathways. Trends Immunol. 2014;35(12):631\u201340.","journal-title":"Trends Immunol"},{"issue":"7343","key":"2317_CR49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nature09788","volume":"472","author":"MA Burguillos","year":"2011","unstructured":"Burguillos MA, et al. Caspase signalling controls microglia activation and neurotoxicity. Nature. 2011;472(7343):319\u201324.","journal-title":"Nature"},{"issue":"12","key":"2317_CR50","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1172\/JCI121901","volume":"128","author":"CJ Zhang","year":"2018","unstructured":"Zhang CJ, et al. TLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation. J Clin Invest. 2018;128(12):5399\u2013412.","journal-title":"J Clin Invest"},{"key":"2317_CR51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng D, Liwinski T, Elinav E. Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov. 2020;6:36.","journal-title":"Cell Discov"},{"issue":"33","key":"2317_CR52","doi-asserted-by":"crossref","first-page":"20167","DOI":"10.1074\/jbc.M115.652321","volume":"290","author":"C Antonopoulos","year":"2015","unstructured":"Antonopoulos C, et al. Caspase-8 as an effector and regulator of NLRP3 inflammasome signaling. J Biol Chem. 2015;290(33):20167\u201384.","journal-title":"J Biol Chem"},{"issue":"9","key":"2317_CR53","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/cdd.2013.37","volume":"20","author":"V Sagulenko","year":"2013","unstructured":"Sagulenko V, et al. AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC. Cell Death Differ. 2013;20(9):1149\u201360.","journal-title":"Cell Death Differ"},{"issue":"6","key":"2317_CR54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007886","volume":"15","author":"AV Goncalves","year":"2019","unstructured":"Goncalves AV, et al. Gasdermin-D and Caspase-7 are the key Caspase-1\/8 substrates downstream of the NAIP5\/NLRC4 inflammasome required for restriction of Legionella pneumophila. PLoS Pathog. 2019;15(6): e1007886.","journal-title":"PLoS Pathog"},{"issue":"8","key":"2317_CR55","volume":"13","author":"DPA Mascarenhas","year":"2017","unstructured":"Mascarenhas DPA, et al. Inhibition of caspase-1 or gasdermin-D enable caspase-8 activation in the Naip5\/NLRC4\/ASC inflammasome. PLoS Pathog. 2017;13(8): e1006502.","journal-title":"PLoS Pathog"},{"issue":"3","key":"2317_CR56","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ni.2222","volume":"13","author":"SI Gringhuis","year":"2012","unstructured":"Gringhuis SI, et al. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1beta via a noncanonical caspase-8 inflammasome. Nat Immunol. 2012;13(3):246\u201354.","journal-title":"Nat Immunol"},{"issue":"6418","key":"2317_CR57","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.aau2818","volume":"362","author":"P Orning","year":"2018","unstructured":"Orning P, et al. Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. Science. 2018;362(6418):1064\u20139.","journal-title":"Science"},{"key":"2317_CR58","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3389\/fimmu.2017.01774","volume":"8","author":"X Zhang","year":"2017","unstructured":"Zhang X, et al. Suppression colitis and colitis-associated colon cancer by anti-S100a9 antibody in mice. Front Immunol. 2017;8:1774.","journal-title":"Front Immunol"},{"issue":"9","key":"2317_CR59","volume":"7","author":"MJ Lee","year":"2012","unstructured":"Lee MJ, et al. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PLoS ONE. 2012;7(9): e38801.","journal-title":"PLoS ONE"},{"key":"2317_CR60","doi-asserted-by":"crossref","first-page":"35014","DOI":"10.1038\/srep35014","volume":"6","author":"T Toyonaga","year":"2016","unstructured":"Toyonaga T, et al. Lipocalin 2 prevents intestinal inflammation by enhancing phagocytic bacterial clearance in macrophages. Sci Rep. 2016;6:35014.","journal-title":"Sci Rep"},{"issue":"9","key":"2317_CR61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044328","volume":"7","author":"B Chassaing","year":"2012","unstructured":"Chassaing B, et al. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS ONE. 2012;7(9): e44328.","journal-title":"PLoS ONE"},{"key":"2317_CR62","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12974-015-0332-6","volume":"12","author":"IC Hoogland","year":"2015","unstructured":"Hoogland IC, et al. Systemic inflammation and microglial activation: systematic review of animal experiments. J Neuroinflammation. 2015;12:114.","journal-title":"J Neuroinflammation"},{"key":"2317_CR63","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbi.2019.05.007","volume":"80","author":"E Dempsey","year":"2019","unstructured":"Dempsey E, et al. Persistent central inflammation and region specific cellular activation accompany depression- and anxiety-like behaviours during the resolution phase of experimental colitis. Brain Behav Immun. 2019;80:616\u201332.","journal-title":"Brain Behav Immun"},{"key":"2317_CR64","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12974-015-0281-0","volume":"12","author":"S Zonis","year":"2015","unstructured":"Zonis S, et al. Chronic intestinal inflammation alters hippocampal neurogenesis. J Neuroinflammation. 2015;12:65.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2317_CR65","doi-asserted-by":"crossref","first-page":"20217","DOI":"10.1038\/s41598-019-56859-0","volume":"9","author":"HM Sroor","year":"2019","unstructured":"Sroor HM, et al. Experimental colitis reduces microglial cell activation in the mouse brain without affecting microglial cell numbers. Sci Rep. 2019;9(1):20217.","journal-title":"Sci Rep"},{"issue":"1","key":"2317_CR66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/exnr.2000.7575","volume":"168","author":"CU Kloss","year":"2001","unstructured":"Kloss CU, et al. Effect of lipopolysaccharide on the morphology and integrin immunoreactivity of ramified microglia in the mouse brain and in cell culture. Exp Neurol. 2001;168(1):32\u201346.","journal-title":"Exp Neurol"},{"issue":"3","key":"2317_CR67","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2982.2005.00654.x","volume":"17","author":"SS Natah","year":"2005","unstructured":"Natah SS, et al. Disruption of the blood-brain barrier during TNBS colitis. Neurogastroenterol Motil. 2005;17(3):433\u201346.","journal-title":"Neurogastroenterol Motil"},{"issue":"5","key":"2317_CR68","first-page":"G1174","volume":"276","author":"CA Hathaway","year":"1999","unstructured":"Hathaway CA, et al. Experimental colitis increases blood\u2013brain barrier permeability in rabbits. Am J Physiol. 1999;276(5):G1174\u201380.","journal-title":"Am J Physiol"},{"key":"2317_CR69","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3389\/fneur.2018.00798","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, et al. Vagus nerve stimulation attenuates cerebral microinfarct and colitis-induced cerebral microinfarct aggravation in mice. Front Neurol. 2018;9:798.","journal-title":"Front Neurol"},{"issue":"7","key":"2317_CR70","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/14728222.2017.1330411","volume":"21","author":"J Austermann","year":"2017","unstructured":"Austermann J, Zenker S, Roth J. S100-alarmins: potential therapeutic targets for arthritis. Expert Opin Ther Targets. 2017;21(7):739\u201351.","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"2317_CR71","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2478\/jtim-2019-0026","volume":"7","author":"Q Wang","year":"2019","unstructured":"Wang Q, Chen W, Lin J. The role of calprotectin in rheumatoid arthritis. J Transl Int Med. 2019;7(4):126\u201331.","journal-title":"J Transl Int Med"},{"issue":"1","key":"2317_CR72","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3904\/kjim.2014.29.1.12","volume":"29","author":"KY Kang","year":"2014","unstructured":"Kang KY, Woo JW, Park SH. S100A8\/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritis. Korean J Intern Med. 2014;29(1):12\u20139.","journal-title":"Korean J Intern Med"},{"issue":"12","key":"2317_CR73","first-page":"2523","volume":"26","author":"P Youssef","year":"1999","unstructured":"Youssef P, et al. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8\/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol. 1999;26(12):2523\u20138.","journal-title":"J Rheumatol"},{"issue":"6143","key":"2317_CR74","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/330080a0","volume":"330","author":"K Odink","year":"1987","unstructured":"Odink K, et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature. 1987;330(6143):80\u20132.","journal-title":"Nature"},{"issue":"2","key":"2317_CR75","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1189\/jlb.0203076","volume":"75","author":"M Frosch","year":"2004","unstructured":"Frosch M, et al. Expression of MRP8 and MRP14 by macrophages is a marker for severe forms of glomerulonephritis. J Leukoc Biol. 2004;75(2):198\u2013206.","journal-title":"J Leukoc Biol"},{"key":"2317_CR76","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108375","volume":"214","author":"SJ Donohue","year":"2020","unstructured":"Donohue SJ, et al. Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE). Clin Immunol. 2020;214: 108375.","journal-title":"Clin Immunol"},{"issue":"10","key":"2317_CR77","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3899\/jrheum.081302","volume":"36","author":"MS Soyfoo","year":"2009","unstructured":"Soyfoo MS, et al. Phagocyte-specific S100A8\/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus. J Rheumatol. 2009;36(10):2190\u20134.","journal-title":"J Rheumatol"},{"issue":"1","key":"2317_CR78","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/096120339300200108","volume":"2","author":"HJ Haga","year":"1993","unstructured":"Haga HJ, et al. Calprotectin in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity. Lupus. 1993;2(1):47\u201350.","journal-title":"Lupus"},{"issue":"8","key":"2317_CR79","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/eurheartj\/ehm078","volume":"28","author":"LA Altwegg","year":"2007","unstructured":"Altwegg LA, et al. Myeloid-related protein 8\/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur Heart J. 2007;28(8):941\u20138.","journal-title":"Eur Heart J"},{"issue":"19","key":"2317_CR80","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1161\/CIRCULATIONAHA.105.607333","volume":"113","author":"AM Healy","year":"2006","unstructured":"Healy AM, et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation. 2006;113(19):2278\u201384.","journal-title":"Circulation"},{"issue":"9","key":"2317_CR81","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/CIRCULATIONAHA.118.039262","volume":"140","author":"Y Li","year":"2019","unstructured":"Li Y, et al. S100a8\/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic\/reperfusion injury. Circulation. 2019;140(9):751\u201364.","journal-title":"Circulation"},{"issue":"1","key":"2317_CR82","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2133.2006.07198.x","volume":"155","author":"S Benoit","year":"2006","unstructured":"Benoit S, et al. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. Br J Dermatol. 2006;155(1):62\u20136.","journal-title":"Br J Dermatol"},{"issue":"6","key":"2317_CR83","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.immuni.2013.11.011","volume":"39","author":"HB Schonthaler","year":"2013","unstructured":"Schonthaler HB, et al. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity. 2013;39(6):1171\u201381.","journal-title":"Immunity"},{"issue":"2\u20133","key":"2317_CR84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3940(98)00263-8","volume":"247","author":"T Bogumil","year":"1998","unstructured":"Bogumil T, et al. Serum levels of macrophage-derived protein MRP-8\/14 are elevated in active multiple sclerosis. Neurosci Lett. 1998;247(2\u20133):195\u20137.","journal-title":"Neurosci Lett"},{"issue":"5","key":"2317_CR85","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/ana.410380514","volume":"38","author":"W Bruck","year":"1995","unstructured":"Bruck W, et al. Monocyte\/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol. 1995;38(5):788\u201396.","journal-title":"Ann Neurol"},{"issue":"1","key":"2317_CR86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/JLB.3COVCRA0720-359R","volume":"109","author":"H Shi","year":"2021","unstructured":"Shi H, et al. Neutrophil calprotectin identifies severe pulmonary disease in COVID-19. J Leukoc Biol. 2021;109(1):67\u201372.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"2317_CR87","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","volume":"182","author":"A Silvin","year":"2020","unstructured":"Silvin A, et al. Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell. 2020;182(6):1401-1418 e18.","journal-title":"Cell"},{"issue":"1","key":"2317_CR88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2013.02.023","volume":"228","author":"L Yan","year":"2013","unstructured":"Yan L, et al. Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null mice. Atherosclerosis. 2013;228(1):69\u201379.","journal-title":"Atherosclerosis"},{"issue":"8","key":"2317_CR89","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/gutjnl-2014-307118","volume":"64","author":"G D'Haens","year":"2015","unstructured":"D\u2019Haens G, et al. A phase II study of laquinimod in Crohn\u2019s disease. Gut. 2015;64(8):1227\u201335.","journal-title":"Gut"},{"key":"2317_CR90","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fnbeh.2018.00058","volume":"12","author":"KD Nyuyki","year":"2018","unstructured":"Nyuyki KD, et al. Altered brain excitability and increased anxiety in mice with experimental colitis: consideration of hyperalgesia and sex differences. Front Behav Neurosci. 2018;12:58.","journal-title":"Front Behav Neurosci"},{"issue":"12","key":"2317_CR91","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1365-2982.2011.01796.x","volume":"23","author":"P Bercik","year":"2011","unstructured":"Bercik P, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011;23(12):1132\u20139.","journal-title":"Neurogastroenterol Motil"},{"issue":"11","key":"2317_CR92","doi-asserted-by":"crossref","first-page":"G989","DOI":"10.1152\/ajpgi.00086.2016","volume":"310","author":"JR Emge","year":"2016","unstructured":"Emge JR, et al. Modulation of the microbiota-gut-brain axis by probiotics in a murine model of inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol. 2016;310(11):G989\u201398.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2317_CR93","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.112802","volume":"216","author":"CE Matisz","year":"2020","unstructured":"Matisz CE, et al. Behavioral adaptations in a relapsing mouse model of colitis. Physiol Behav. 2020;216: 112802.","journal-title":"Physiol Behav"},{"key":"2317_CR94","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1742-2094-11-132","volume":"11","author":"J Cazareth","year":"2014","unstructured":"Cazareth J, et al. Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2\/CCL2 signaling. J Neuroinflammation. 2014;11:132.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"2317_CR95","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbi.2007.08.014","volume":"22","author":"J Chen","year":"2008","unstructured":"Chen J, et al. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun. 2008;22(3):301\u201311.","journal-title":"Brain Behav Immun"},{"key":"2317_CR96","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12974-014-0220-5","volume":"12","author":"PK Fruhauf","year":"2015","unstructured":"Fruhauf PK, et al. Spermine reverses lipopolysaccharide-induced memory deficit in mice. J Neuroinflammation. 2015;12:3.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"2317_CR97","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453\u201362.","journal-title":"Glia"},{"issue":"2","key":"2317_CR98","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.expneurol.2007.01.003","volume":"204","author":"A Semmler","year":"2007","unstructured":"Semmler A, et al. Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp Neurol. 2007;204(2):733\u201340.","journal-title":"Exp Neurol"},{"key":"2317_CR99","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1742-2094-9-101","volume":"9","author":"P Bossu","year":"2012","unstructured":"Bossu P, et al. A single intraperitoneal injection of endotoxin in rats induces long-lasting modifications in behavior and brain protein levels of TNF-alpha and IL-18. J Neuroinflammation. 2012;9:101.","journal-title":"J Neuroinflammation"},{"issue":"11","key":"2317_CR100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142195","volume":"10","author":"AM Stankiewicz","year":"2015","unstructured":"Stankiewicz AM, et al. The effect of acute and chronic social stress on the hippocampal transcriptome in mice. PLoS ONE. 2015;10(11): e0142195.","journal-title":"PLoS ONE"},{"issue":"9","key":"2317_CR101","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.4049\/jimmunol.1700834","volume":"200","author":"SJ Denstaedt","year":"2018","unstructured":"Denstaedt SJ, et al. S100A8\/A9 drives neuroinflammatory priming and protects against anxiety-like behavior after sepsis. J Immunol. 2018;200(9):3188\u2013200.","journal-title":"J Immunol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02317-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-021-02317-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-021-02317-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T08:06:26Z","timestamp":1636531586000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-021-02317-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2317"],"URL":"https:\/\/doi.org\/10.1186\/s12974-021-02317-6","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"assertion":[{"value":"16 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal work was performed in compliance with the Institutional Animal Care and Use Committee (IACUC) at Loyola University, Chicago (protocol approval numbers 2021003, 2017032, 2019009, 2020023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}